Toxys reports positive results from the OECD ring trial validation


ToxTracker is an in vitro method that accurately predicts genotoxicity without the use of animals. The results constitute an essential part of the approval process by the OECD for international acceptance of novel methods by regulatory authorities.

The evaluation was finalized earlier in the year and data have been submitted to the OECD showing that ToxTracker consistently demonstrates high accuracy and excellent reproducibility of test results, both within and between different laboratories. These data prove that ToxTracker is both robust and reliable. Importantly, ToxTracker can provide insight into the mode of action of genotoxic compounds thereby significantly improving the in vitro safety assessment of novel pharmaceutical products, chemicals, cosmetics and food-related products.

Visit the page below for the full press release and a link to the publication:

Toxys publication on OECD ring trial validation of ToxTracker


  • VitroScan Achieves ISO‑15189 Compliance

    A Crucial Step Toward Introducing Predictive Testing Services into Clinical Practice Leiden, The Netherlands, 10 March 2026 — VitroScan is a Dutch biotech company developing predictive ex vivo micro‑tumor testing to help physicians make informed cancer treatment decisions. Today VitroScan announced that…

  • University Sportcentrum has Opened

    The University Sports Centre (USC) has been renovated, and we would love to take you on a quick tour of the building. Whether you are a colleague at LBSP, a student, or an external sports enthusiast: everyone is welcome to…